{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:10:19Z","timestamp":1777457419011,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11823-w","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:17:36Z","timestamp":1777375056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin as a potential therapeutic agent in broken heart syndrome: Targeting AMPK-dependent cardio-protection and microvascular function"],"prefix":"10.1007","volume":"53","author":[{"given":"Muhannad","family":"Almubarak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar R.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda J.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"3","key":"11823_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.JAA.0000654368.35241.fc","volume":"33","author":"B Boyd","year":"2020","unstructured":"Boyd B, Solh T (2020) Takotsubo cardiomyopathy: Review of broken heart syndrome. Jaapa 33(3):24\u201329","journal-title":"Jaapa"},{"key":"11823_CR2","doi-asserted-by":"crossref","unstructured":"Sethi Y et al (2022) Broken Heart Syndrome: Evolving Molecular Mechanisms and Principles of Management. J Clin Med, 12(1):125","DOI":"10.3390\/jcm12010125"},{"issue":"3","key":"11823_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/hm.HM-D-24-00114","volume":"9","author":"F Cacciapuoti","year":"2025","unstructured":"Cacciapuoti F et al (2025) Beyond the Broken Heart: Unusual Triggers of Stress Cardiomyopathy\u2013A Narrative Review. Heart Mind 9(3):215\u2013223","journal-title":"Heart Mind"},{"key":"11823_CR4","doi-asserted-by":"crossref","unstructured":"Casagrande M et al (2021) The Broken Heart: The Role of Life Events in Takotsubo Syndrome. J Clin Med, 10(21):4940","DOI":"10.3390\/jcm10214940"},{"issue":"3","key":"11823_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2011.992","volume":"306","author":"I Eitel","year":"2011","unstructured":"Eitel I et al (2011) Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA 306(3):277\u2013286","journal-title":"JAMA"},{"issue":"7","key":"11823_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4330\/wjc.v5.i7.228","volume":"5","author":"EF Sanchez-Jimenez","year":"2013","unstructured":"Sanchez-Jimenez EF (2013) Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases. World J Cardiol 5(7):228\u2013241","journal-title":"World J Cardiol"},{"issue":"7","key":"11823_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrcardio.2015.39","volume":"12","author":"YJ Akashi","year":"2015","unstructured":"Akashi YJ, Nef HM, Lyon AR (2015) Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol 12(7):387\u2013397","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"11823_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.hfc.2021.08.001","volume":"18","author":"R Citro","year":"2022","unstructured":"Citro R et al (2022) Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome. Heart Fail Clin 18(1):125\u2013137","journal-title":"Heart Fail Clin"},{"key":"11823_CR9","doi-asserted-by":"publisher","first-page":"132432","DOI":"10.1016\/j.ijcard.2024.132432","volume":"414","author":"FJ Romeo","year":"2024","unstructured":"Romeo FJ (2024) When the heart truly breaks: Cardiac rupture in broken heart syndrome. Int J Cardiol 414:132432","journal-title":"Int J Cardiol"},{"issue":"5","key":"11823_CR10","first-page":"490","volume":"15","author":"MG Vailas","year":"2017","unstructured":"Vailas MG et al (2017) A Trapped Heart in an Octopus Pot: Takotsubo Cardiomyopathy; Review of a Rare Clinical Syndrome Following Solid-Organ Transplant. Exp Clin Transpl 15(5):490\u2013496","journal-title":"Exp Clin Transpl"},{"issue":"2","key":"11823_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jpsychores.2014.05.003","volume":"77","author":"C Lacey","year":"2014","unstructured":"Lacey C et al (2014) Broken heart syndrome -- is it a psychosomatic disorder? J Psychosom Res 77(2):158\u2013160","journal-title":"J Psychosom Res"},{"issue":"5","key":"11823_CR12","first-page":"451","volume":"51","author":"S Koulouris","year":"2010","unstructured":"Koulouris S et al (2010) Takotsubo cardiomyopathy: the broken heart syndrome. Hellenic J Cardiol 51(5):451\u2013457","journal-title":"Hellenic J Cardiol"},{"issue":"7","key":"11823_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jchf.2022.02.016","volume":"10","author":"J Adu-Amankwaah","year":"2022","unstructured":"Adu-Amankwaah J (2022) Happy Heart Versus Broken Heart Syndrome: The 2 Faces of Takotsubo Syndrome: Similarities and Differences. JACC Heart Fail 10(7):467\u2013469","journal-title":"JACC Heart Fail"},{"issue":"8","key":"11823_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/djac116","volume":"114","author":"MS Linet","year":"2022","unstructured":"Linet MS, Dores GM, Savage SA (2022) Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart. J Natl Cancer Inst 114(8):1054\u20131056","journal-title":"J Natl Cancer Inst"},{"key":"11823_CR15","doi-asserted-by":"crossref","unstructured":"Marano G et al (2025) When a Woman\u2019s Heart Fails to Contain: Takotsubo Syndrome as a Gendered Collapse of Emotional Regulation. Life (Basel), 15(9): 1431","DOI":"10.3390\/life15091431"},{"issue":"5570","key":"11823_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.4.5570.13","volume":"4","author":"WD Rees","year":"1967","unstructured":"Rees WD, Lutkins SG (1967) Mortality of bereavement. Br Med J 4(5570):13\u201316","journal-title":"Br Med J"},{"issue":"5","key":"11823_CR17","doi-asserted-by":"publisher","first-page":"771","DOI":"10.7326\/0003-4819-74-5-771","volume":"74","author":"GL Engel","year":"1971","unstructured":"Engel GL (1971) Sudden and rapid death during psychological stress. Folklore or folk wisdom? Ann Intern Med 74(5):771\u2013782","journal-title":"Ann Intern Med"},{"issue":"2","key":"11823_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0046-8177(80)80129-8","volume":"11","author":"MS Cebelin","year":"1980","unstructured":"Cebelin MS, Hirsch CS (1980) Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol 11(2):123\u2013132","journal-title":"Hum Pathol"},{"issue":"3","key":"11823_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijcard.2012.09.183","volume":"166","author":"YH S","year":"2013","unstructured":"S YH, Yamasaki K (2013) History of takotsubo syndrome: is the syndrome really described as a disease entity first in 1990? Some inaccuracies. Int J Cardiol 166(3):736\u2013737","journal-title":"Int J Cardiol"},{"issue":"1","key":"11823_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10557-019-06918-5","volume":"34","author":"GJ Ong","year":"2020","unstructured":"Ong GJ et al (2020) Incremental Therapeutic Myocardial Exposure to Catecholamines: Incidence and Impact in Takotsubo Syndrome. Cardiovasc Drugs Ther 34(1):95\u2013100","journal-title":"Cardiovasc Drugs Ther"},{"key":"11823_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2014.11.149","volume":"181","author":"YH S","year":"2015","unstructured":"S YH, Henareh L (2015) Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease. Int J Cardiol 181:35\u201338","journal-title":"Int J Cardiol"},{"key":"11823_CR22","doi-asserted-by":"crossref","unstructured":"Koch HJ (2013) Psychophysiological concepts of stress induced cardiomyopathy with broken heart syndrome as a paradigm, vol 15. Archives of Psychiatry & Psychotherapy, 2","DOI":"10.12740\/APP\/18442"},{"key":"11823_CR23","first-page":"149","volume":"9","author":"B Redfors","year":"2013","unstructured":"Redfors B, Shao Y, Omerovic E (2013) Stress-induced cardiomyopathy (Takotsubo)--broken heart and mind? Vasc Health Risk Manag 9:149\u2013154","journal-title":"Vasc Health Risk Manag"},{"key":"11823_CR24","doi-asserted-by":"crossref","unstructured":"Golzar Y, Doukky R (2025) Broken Heart Does Not Forget: Persistent Microvascular Dysfunction in Takotsubo Syndrome. Circ Cardiovasc Imaging, p e018881","DOI":"10.1161\/CIRCIMAGING.125.018881"},{"issue":"6","key":"11823_CR25","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.21037\/cdt-23-283","volume":"13","author":"J Salamanca","year":"2023","unstructured":"Salamanca J, Alfonso F (2023) Takotsubo syndrome: unravelling the enigma of the broken heart syndrome?-a narrative review. Cardiovasc Diagn Ther 13(6):1080\u20131103","journal-title":"Cardiovasc Diagn Ther"},{"key":"11823_CR26","doi-asserted-by":"crossref","unstructured":"Xiang W et al (2023) Unveiling catecholamine dynamics in cardiac health and disease: Mechanisms, implications, and future perspectives. Int J Drug Discovery Pharmacol p 12\u201322","DOI":"10.53941\/ijddp.2023.100012"},{"key":"11823_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijcard.2016.12.124","volume":"230","author":"ND Brunetti","year":"2017","unstructured":"Brunetti ND et al (2017) Combined therapy with beta-blockers and ACE-inhibitors\/angiotensin receptor blockers and recurrence of Takotsubo (stress) cardiomyopathy: A meta-regression study. Int J Cardiol 230:281\u2013283","journal-title":"Int J Cardiol"},{"key":"11823_CR28","doi-asserted-by":"crossref","unstructured":"Madias JE (2021) Takotsubo Cardiomyopathy: Current Treatment. J Clin Med 10(15):3440","DOI":"10.3390\/jcm10153440"},{"issue":"5","key":"11823_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/ijbs.29680","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang F et al (2019) Metformin Inhibits the NLRP3 Inflammasome via AMPK\/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Biol Sci 15(5):1010\u20131019","journal-title":"Int J Biol Sci"},{"issue":"4","key":"11823_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/JLP.JLP_123_19","volume":"11","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM et al (2019) Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus. J Lab Physicians 11(4):317\u2013322","journal-title":"J Lab Physicians"},{"issue":"5","key":"11823_CR31","doi-asserted-by":"publisher","first-page":"e22243","DOI":"10.1002\/ddr.22243","volume":"85","author":"Z Al-Qahtani","year":"2024","unstructured":"Al-Qahtani Z et al (2024) Kynurenine pathway in type 2 diabetes: Role of metformin. Drug Dev Res 85(5):e22243","journal-title":"Drug Dev Res"},{"issue":"8","key":"11823_CR32","doi-asserted-by":"publisher","first-page":"e1346","DOI":"10.1002\/iid3.1346","volume":"12","author":"A Turkistani","year":"2024","unstructured":"Turkistani A et al (2024) Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insight. Immun Inflamm Dis 12(8):e1346","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"11823_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/japtr.JAPTR_18_20","volume":"11","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM et al (2020) Metformin and\/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect. J Adv Pharm Technol Res 11(3):142\u2013147","journal-title":"J Adv Pharm Technol Res"},{"issue":"11","key":"11823_CR34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1080\/15548627.2024.2367356","volume":"20","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM et al (2024) Dysregulation of pancreatic \u03b2-cell autophagy and the risk of type 2 diabetes. Autophagy 20(11):2361\u20132372","journal-title":"Autophagy"},{"issue":"1","key":"11823_CR35","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1038\/s41598-022-09384-6","volume":"12","author":"SI Abd-El Hafeez","year":"2022","unstructured":"Abd-El Hafeez SI et al (2022) Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers. Sci Rep 12(1):5737","journal-title":"Sci Rep"},{"issue":"9","key":"11823_CR36","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1002\/jps.23595","volume":"102","author":"N Nakamichi","year":"2013","unstructured":"Nakamichi N et al (2013) Involvement of carnitine\/organic cation transporter OCTN1\/SLC22A4 in gastrointestinal absorption of metformin. J Pharm Sci 102(9):3407\u20133417","journal-title":"J Pharm Sci"},{"issue":"2","key":"11823_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12020-023-03550-0","volume":"83","author":"SA Paschou","year":"2024","unstructured":"Paschou SA et al (2024) Efficacy and safety of metformin during pregnancy: an update. Endocrine 83(2):259\u2013269","journal-title":"Endocrine"},{"issue":"3","key":"11823_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2174\/0115748863308106240816044733","volume":"20","author":"MS Hussain","year":"2025","unstructured":"Hussain MS et al (2025) Long-Term Use of Metformin and Vitamin B12 Deficiency in Diabetes. Curr Drug Saf 20(3):258\u2013270","journal-title":"Curr Drug Saf"},{"issue":"3","key":"11823_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40256-018-0266-3","volume":"18","author":"L Varjabedian","year":"2018","unstructured":"Varjabedian L et al (2018) Cardioprotection by Metformin: Beneficial Effects Beyond Glucose Reduction. Am J Cardiovasc Drugs 18(3):181\u2013193","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"11823_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11883-013-0314-z","volume":"15","author":"S El Messaoudi","year":"2013","unstructured":"El Messaoudi S, Rongen GA, Riksen NP (2013) Metformin therapy in diabetes: the role of cardioprotection. Curr Atheroscler Rep 15(4):314","journal-title":"Curr Atheroscler Rep"},{"key":"11823_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.12.030","volume":"772","author":"H Vaez","year":"2016","unstructured":"Vaez H et al (2016) Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Eur J Pharmacol 772:115\u2013123","journal-title":"Eur J Pharmacol"},{"key":"11823_CR42","doi-asserted-by":"crossref","unstructured":"Zilinyi R et al (2018) The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy. Molecules 23(5):1184.","DOI":"10.3390\/molecules23051184"},{"issue":"19","key":"11823_CR43","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.1111\/jcmm.17519","volume":"26","author":"Y Bu","year":"2022","unstructured":"Bu Y et al (2022) Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med 26(19):4886\u20134903","journal-title":"J Cell Mol Med"},{"issue":"1","key":"11823_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1365-2796.2004.01420.x","volume":"257","author":"J De Jager","year":"2005","unstructured":"De Jager J et al (2005) Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 257(1):100\u2013109","journal-title":"J Intern Med"},{"issue":"5","key":"11823_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.trsl.2015.06.002","volume":"166","author":"W Xu","year":"2015","unstructured":"Xu W et al (2015) Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. Transl Res 166(5):451\u2013458","journal-title":"Transl Res"},{"issue":"15","key":"11823_CR46","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CP Lexis","year":"2014","unstructured":"Lexis CP et al (2014) Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA 311(15):1526\u20131535","journal-title":"JAMA"},{"issue":"5","key":"11823_CR47","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacc.2006.04.088","volume":"48","author":"S Jadhav","year":"2006","unstructured":"Jadhav S et al (2006) Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 48(5):956\u2013963","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"11823_CR48","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.2337\/dc21-0433","volume":"44","author":"P Paolisso","year":"2021","unstructured":"Paolisso P et al (2021) Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators. Diabetes Care 44(9):2158\u20132161","journal-title":"Diabetes Care"},{"key":"11823_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amjcard.2024.11.022","volume":"237","author":"Y Watanabe","year":"2025","unstructured":"Watanabe Y et al (2025) Prevalence and Prognostic Impact of Diabetes in Takotsubo Syndrome: Insights from the Tokyo Cardiovascular Care Unit Network Registry. Am J Cardiol 237:29\u201334","journal-title":"Am J Cardiol"},{"key":"11823_CR50","doi-asserted-by":"crossref","unstructured":"Nakamura K et al (2022) Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus. Int J Mol Sci 23(7):3587","DOI":"10.3390\/ijms23073587"},{"issue":"10","key":"11823_CR51","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s11886-023-01944-0","volume":"25","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jia H, Song J (2023) Accurate Classification of Non-ischemic Cardiomyopathy. Curr Cardiol Rep 25(10):1299\u20131317","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"11823_CR52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/FJC.0000000000001172","volume":"79","author":"VR Peterson","year":"2022","unstructured":"Peterson VR et al (2022) Metformin Prevents Low-dose Isoproterenol-induced Cardiac Dilatation and Systolic Dysfunction in Male Sprague Dawley Rats. J Cardiovasc Pharmacol 79(3):289\u2013295","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"11823_CR53","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10554-025-03477-9","volume":"41","author":"R Cau","year":"2025","unstructured":"Cau R et al (2025) Heart-Brain axis: is microvascular dysfunction the link between stroke and Takotsubo syndrome? Int J Cardiovasc Imaging 41(10):1895\u20131906","journal-title":"Int J Cardiovasc Imaging"},{"key":"11823_CR54","doi-asserted-by":"crossref","unstructured":"Sousa D et al (2025) MicroRNAs in Takotsubo Syndrome. A Systematic Review of Regulatory Networks in Stress-Induced Cardiomyopathy. Int J Mol Sci 26(19)","DOI":"10.3390\/ijms26199790"},{"issue":"15","key":"11823_CR55","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/eurheartj\/ehz068","volume":"40","author":"C Templin","year":"2019","unstructured":"Templin C et al (2019) Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome. Eur Heart J 40(15):1183\u20131187","journal-title":"Eur Heart J"},{"key":"11823_CR56","doi-asserted-by":"publisher","first-page":"p4150291","DOI":"10.1155\/2020\/4150291","volume":"2020","author":"X Wang","year":"2020","unstructured":"Wang X, Pei J, Hu X (2020) The Brain-Heart Connection in Takotsubo Syndrome: The Central Nervous System, Sympathetic Nervous System, and Catecholamine Overload. Cardiol Res Pract 2020:p4150291","journal-title":"Cardiol Res Pract"},{"key":"11823_CR57","doi-asserted-by":"publisher","first-page":"660793","DOI":"10.3389\/fendo.2021.660793","volume":"12","author":"C Franco","year":"2021","unstructured":"Franco C et al (2021) Metformin Improves Autonomic Nervous System Imbalance and Metabolic Dysfunction in Monosodium L-Glutamate-Treated Rats. Front Endocrinol (Lausanne) 12:660793","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"11823_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.numecd.2019.09.005","volume":"30","author":"PWC Oliveira","year":"2020","unstructured":"Oliveira PWC et al (2020) Chronic metformin reduces systemic and local inflammatory proteins and improves hypertension-related cardiac autonomic dysfunction. Nutr Metab Cardiovasc Dis 30(2):274\u2013281","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"11823_CR59","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s11010-021-04194-2","volume":"476","author":"LN Ionic\u0103","year":"2021","unstructured":"Ionic\u0103 LN et al (2021) Metformin alleviates monoamine oxidase-related vascular oxidative stress and endothelial dysfunction in rats with diet-induced obesity. Mol Cell Biochem 476(11):4019\u20134029","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"11823_CR60","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2459\/JCM.0000000000000500","volume":"18","author":"G Pizzino","year":"2017","unstructured":"Pizzino G et al (2017) Takotsubo syndrome and estrogen receptor genes: partners in crime? J Cardiovasc Med (Hagerstown) 18(4):268\u2013276","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"11823_CR61","first-page":"e22845","volume":"14","author":"A Waqar","year":"2022","unstructured":"Waqar A et al (2022) Cardioprotective Role of Estrogen in Takotsubo Cardiomyopathy. Cureus 14(3):e22845","journal-title":"Cureus"},{"key":"11823_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijcard.2017.10.047","volume":"250","author":"C M\u00f6ller","year":"2018","unstructured":"M\u00f6ller C et al (2018) Comprehensive assessment of sex hormones in Takotsubo syndrome. Int J Cardiol 250:11\u201315","journal-title":"Int J Cardiol"},{"issue":"6","key":"11823_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clbc.2013.08.012","volume":"13","author":"C Campagnoli","year":"2013","unstructured":"Campagnoli C et al (2013) Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clin Breast Cancer 13(6):433\u2013438","journal-title":"Clin Breast Cancer"},{"issue":"24","key":"11823_CR64","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/eurheartj\/ehad274","volume":"44","author":"F Dong","year":"2023","unstructured":"Dong F et al (2023) Takotsubo syndrome is a coronary microvascular disease: experimental evidence. Eur Heart J 44(24):2244\u20132253","journal-title":"Eur Heart J"},{"issue":"1","key":"11823_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.echo.2007.05.024","volume":"21","author":"P Meimoun","year":"2008","unstructured":"Meimoun P et al (2008) The coronary flow reserve is transiently impaired in tako-tsubo cardiomyopathy: a prospective study using serial Doppler transthoracic echocardiography. J Am Soc Echocardiogr 21(1):72\u201377","journal-title":"J Am Soc Echocardiogr"},{"key":"11823_CR66","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2021.03.033","volume":"169","author":"T M\u00fcnzel","year":"2021","unstructured":"M\u00fcnzel T et al (2021) Takotsubo Syndrome: Impact of endothelial dysfunction and oxidative stress. Free Radic Biol Med 169:216\u2013223","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"11823_CR67","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10735-018-9801-4","volume":"49","author":"AAM Abdel-Hamid","year":"2018","unstructured":"Abdel-Hamid AAM, Firgany AEL (2018) Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy. J Mol Histol 49(6):639\u2013649","journal-title":"J Mol Histol"},{"issue":"1","key":"11823_CR68","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-017-0525-7","volume":"16","author":"J van Haare","year":"2017","unstructured":"van Haare J et al (2017) Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats. Cardiovasc Diabetol 16(1):47","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"11823_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2265.2006.02551.x","volume":"65","author":"S Topcu","year":"2006","unstructured":"Topcu S et al (2006) Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance. Clin Endocrinol (Oxf) 65(1):75\u201380","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"11823_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-019-0931-0","volume":"18","author":"C Sardu","year":"2019","unstructured":"Sardu C et al (2019) Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin. Cardiovasc Diabetol 18(1):126","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"11823_CR71","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/1440-1681.13148","volume":"46","author":"HM Karam","year":"2019","unstructured":"Karam HM, Radwan RR (2019) Metformin modulates cardiac endothelial dysfunction, oxidative stress and inflammation in irradiated rats: A new perspective of an antidiabetic drug. Clin Exp Pharmacol Physiol 46(12):1124\u20131132","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"11823_CR72","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1567202617666191223144715","volume":"17","author":"S Mao","year":"2020","unstructured":"Mao S et al (2020) Role of PI3K\/AKT\/mTOR Pathway Associated Oxidative Stress and Cardiac Dysfunction in Takotsubo Syndrome. Curr Neurovasc Res 17(1):35\u201343","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"11823_CR73","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00395-007-0691-y","volume":"103","author":"GS Bhamra","year":"2008","unstructured":"Bhamra GS et al (2008) Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 103(3):274\u2013284","journal-title":"Basic Res Cardiol"},{"issue":"23","key":"11823_CR74","doi-asserted-by":"publisher","first-page":"24270","DOI":"10.18632\/aging.202143","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang J et al (2020) Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway. Aging 12(23):24270\u201324287","journal-title":"Aging"},{"key":"11823_CR75","doi-asserted-by":"crossref","unstructured":"Borodzicz-Ja\u017cd\u017cyk S et al (2023) Inflammatory Forms of Cardiomyocyte Cell Death in the Rat Model of Isoprenaline-Induced Takotsubo Syndrome. Biomedicines 11(7)","DOI":"10.3390\/biomedicines11072060"},{"issue":"34","key":"11823_CR76","doi-asserted-by":"publisher","first-page":"36441","DOI":"10.18632\/oncotarget.5541","volume":"6","author":"L Ding","year":"2015","unstructured":"Ding L et al (2015) Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages. Oncotarget 6(34):36441\u201336455","journal-title":"Oncotarget"},{"issue":"6","key":"11823_CR77","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/db14-1225","volume":"64","author":"SB Vasamsetti","year":"2015","unstructured":"Vasamsetti SB et al (2015) Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis. Diabetes 64(6):2028\u20132041","journal-title":"Diabetes"},{"key":"11823_CR78","doi-asserted-by":"crossref","unstructured":"Liao X et al (2022) Cardiac macrophages regulate isoproterenol-induced Takotsubo-like cardiomyopathy. JCI Insight 7(3):e156236","DOI":"10.1172\/jci.insight.156236"},{"key":"11823_CR79","doi-asserted-by":"crossref","unstructured":"Fan X et al (2022) Takotsubo Syndrome: Translational Implications and Pathomechanisms. Int J Mol Sci 23(4):1951","DOI":"10.3390\/ijms23041951"},{"key":"11823_CR80","unstructured":"Cai H, Zhang G, Chen W, Zhang B, Zhang J, Chang J, Tang C, Qi Y, Yin X. Metformin protects the myocardium against isoproterenol-induced injury in rats through alleviating endoplasmic reticulum stress. Pharmazie. 2014 Jan;69(1):64-9."}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11823-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11823-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:04:33Z","timestamp":1777381473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11823-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11823"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11823-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"688"}}